Treatment of refractory rheumatoid arthritis with a chimeric anti-CD4 monoclonal antibody. Long-term followup of CD4+ T cell counts.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Arthritis & Rheumatism

• Publication date

  1994-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ART.1780370610PMID 7911664
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis. Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression.

  2010cited by this paper
• Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis.

  1993cited by this paper
• Persistent depletion of CD4+ T cells and inversion of the CD4/CD8 T cell ratio induced by anti-CD4 therapy.

  1992cited by this paper
• Pneumocystis carinii pneumonia due to corticosteroids.

  1992cited by this paper
• Effect of protein malnutrition and immunomodulation on immune cell populations.

  1992cited by this paper
• Effects of intravenous and oral dexamethasone on selected lymphocyte subpopulations in normal subjects.

  1992cited by this paper
• Pneumocystis carinii pneumonia due to corticosteroids.

  1992cited by this paper
• Protein-energy malnutrition and immunological responses.

  1992cited by this paper
• Nutrition and immunoregulation. Significance for host resistance to tumors and infectious diseases in humans and rodents.

  1992cited by this paper
• Pneumocystis carinii infection complicating cytotoxic therapy in two patients with lymphopenia, but a normal total white cell count.

  1992cited by this paper
• Acute and chronic suppression of leukotriene B4 synthesis ex vivo in neutrophils from patients with rheumatoid arthritis beginning treatment with methotrexate.

  1992cited by this paper
• Cytomegalovirus pneumonia in a patient with rheumatoid arthritis treated with low dose methotrexate and prednisone.

  1991cited by this paper
• Herpes simplex hepatitis in a patient with psoriatic arthritis taking prednisone and methotrexate. Report and review of the literature.

  1991cited by this paper
• Complications of immunosuppression associated with weekly low dose methotrexate.

  1991cited by this paper
• Impaired macrophage function in severe protein-energy malnutrition.

  1991cited by this paper
• Nocardia asteroides infection complicating rheumatoid arthritis.

  1991cited by this paper
• Superiority of methylprednisolone over dexamethasone for induction of Pneumocystis carinii infection in rats

  1991cited by this paper
• Nocardia asteroides pneumonia complicating low dose methotrexate treatment of refractory rheumatoid arthritis.

  1991cited by this paper
• Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells.

  1991cited by this paper
• Herpes zoster in patients with rheumatoid arthritis treated with weekly, low-dose methotrexate.

  1991cited by this paper
• Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis.

  1991cited by this paper
• [Lung diseases and treatment with methotrexate in rheumatoid arthritis].

  1991cited by this paper
• Pneumocystis carinii pneumonia as a complication of methotrexate treatment of asthma.

  1991cited by this paper
• Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody.

  1991cited by this paper
• Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.

  1991cited by this paper
• Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration.

  1991cited by this paper
• Pneumocystis carinii pneumonia associated with methotrexate therapy in rheumatoid arthritis.

  1991cited by this paper
• Low dose methotrexate therapy for rheumatoid arthritis complicated by pancytopenia and Pneumocystis carinii pneumonia.

  1991cited by this paper
• Methotrexate: mechanism of action in rheumatoid arthritis.

  1990cited by this paper
• The effect of antirheumatic drugs on interleukin 1 (IL-1) activity and IL-1 and IL-1 inhibitor production by human monocytes.

  1990cited by this paper
• Response of immunoregulatory lymphocyte subsets to methotrexate in rheumatoid arthritis.

  1990cited by this paper
• Rheumatoid arthritis, methotrexate therapy, and Pneumocystis pneumonia.

  1990cited by this paper
• Antiproliferative effects of methotrexate on peripheral blood mononuclear cells.

  1989cited by this paper
• Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for psoriatic arthropathy.

  1989cited by this paper
• Immunomodulation by low-dose methotrexate. I. Methotrexate selectively inhibits Lyt-2+ cells in murine acute graft-versus-host reactions.

  1989cited by this paper
• Nocardiosis associated with low dose methotrexate for rheumatoid arthritis.

  1988cited by this paper
• Cryptococcosis associated with low-dose methotrexate for arthritis.

  1987cited by this paper
• Toxicity of methotrexate in rheumatoid arthritis.

  1987cited by this paper
• Pneumocystis Carinii Pneumonia: A Lethal Complication of “Pulse” Methylprednisolone Therapy

  1987cited by this paper
• Comparative effects on the immune system of methotrexate and trimetrexate.

  1987cited by this paper
• Experimental Pneumocystis carinii pneumonia in the ferret.

  1987cited by this paper
• Excess prevalence of Pneumocystis carinii pneumonia in patients treated for lymphoma with combination chemotherapy.

  1986cited by this paper
• Predisposing factors in Pneumocystis carinii pneumonia: effects of tetracycline, protein malnutrition, and corticosteroids on hosts

  1984cited by this paper
• Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years.

  1984cited by this paper
• Pneumocystis carinii pneumonia following methotrexate therapy for rheumatoid arthritis.

  1983cited by this paper
• Marasmus and pneumocystis carinii pneumonia in institutionalised infants

  1974cited by this paper

• Lymphopenia and Mechanisms of T-Cell Regeneration

  2022cites this paper
• OX40-Fc Fusion Protein Alleviates PD-1-Fc-Aggravated Rheumatoid Arthritis by Inhibiting Inflammatory Response

  2022cites this paper
• Preclinical Targeting of Human Acute Myeloid Leukemia Using CD4-specific Chimeric Antigen Receptor (CAR) T Cells and NK Cells

  2019cites this paper
• Adaptationen von T Helferlymphozyten an chronische Entzündungen

  2018cites this paper
• Preclinical targeting of human T-cell malignancies using CD4-specific chimeric antigen receptor (CAR)-engineered T cells

  2016cites this paper
• Pathogenesis of rheumatoid arthritis

  2016cites this paper
• Foxp3+ T cells inhibit antitumor immune memory modulated by mTOR inhibition.

  2014cites this paper
• Treatment of Autoimmune Disease: Biological and Molecular Therapies

  2014cites this paper
• Functional and genetic analyses of the MHC and its impact on autoimmunity in the rat

  2013cites this paper
• refractory cutaneous T-cell lymphoma Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in

  2013cites this paper
• Role of Human CD4 D1D2 Domain in HIV-1 Infection

  2013cites this paper
• Molecular characterization of woodchuck CD4 (wCD4) and production of a depletion monoclonal antibody against wCD4.

  2013cites this paper
• MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments

  2011cites this paper
• Immunotoxicology of Biopharmaceutics

  2010cites this paper
• HIV and the Sharpen Edge Between Protective and Pathogenic Immune Responses to the CD4 Self Antigen

  2010cites this paper
• Perspectives in targeted therapy

  2009cites this paper
• Journal of Translational Medicine Protective versus Pathogenic Anti-cd4 Immunity: Insights from the Study of Natural Resistance to Hiv Infection

  2009cites this paper
• [New therapeutic targets for antibodies and recombinant proteins in organ transplantation].

  2008cites this paper
• Anti-proliferative effects induced by anti-CD4 human/murine chimeric antibody and murine anti-CD4 monoclonal antibody

  2008cites this paper
• Nouvelles biothérapies immunosuppressives dans les transplantations d’organes

  2008cites this paper
• Biologic therapies in rheumatology: lessons learned, future directions

  2007cites this paper
• Inhibition of cytokine production by methotrexate . Studies in healthy volunteers and patients with rheumatoid arthritis

  2007cites this paper
• Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma.

  2007cites this paper
• New therapeutic targets for antibodies and recombinant proteins in organ transplantation.

  2007cites this paper
• UvA-DARE ( Digital Academic Repository ) Inhibition of cytokine production by methotrexate . Studies in healthy volunteers and patients with rheumatoid arthritis

  2007cites this paper
• Emerging Therapies for Autoimmune Diseases

  2006cites this paper
• Monoclonal antibody-based strategies in autoimmunity and transplantation.

  2005cites this paper
• Current biological therapies for inflammatory bowel disease.

  2004cites this paper
• Anti-CD4 monoclonal antibodies in rheumatoid arthritis

  2004cites this paper
• CELL DYNAMICS IN HIV-1 INFECTION ∗

  2003cites this paper
• Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft

  2003cites this paper
• TNF receptor gene therapy results in suppression of IgG2a anticollagen antibody in collagen induced arthritis

  2003cites this paper
• Biologische Therapie chronisch-entzündlicher Darmerkrankungen

  2003cites this paper
• [Biologic therapy of inflammatory bowel disease].

  2003cites this paper
• Donor‐specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft

  2003cites this paper
• T cell dynamics in HIV-1 infection.

  2003cites this paper
• Immune Modulator Studies in Primates: The Utility of Flow Cytometry and Immunohistochemistry in the Identification and Characterization of Immunotoxicity

  2003cites this paper
• The use of monoclonal antibodies to restore self-tolerance in established autoimmunity.

  2002cites this paper
• Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion.

  2002cites this paper
• Differential clinical efficacy of anti-CD4 monoclonal antibodies in rat adjuvant arthritis is paralleled by differential influence on NF-κB binding activity and TNF-α secretion of T cells

  2002cites this paper
• Reconstitution of naive T cells during antiretroviral treatment of HIV-infected adults is dependent on age

  2002cites this paper
• Advances in the management of psoriasis: monoclonal antibody therapies

  2002cites this paper
• Repeat-cycle study of high-dose intravenous 4162W94 anti-CD4 humanized monoclonal antibody in rheumatoid arthritis. A randomized placebo-controlled trial.

  2002cites this paper
• Therapeutic anti-T-cell monoclonal antibodies

  2001cites this paper
• Potential biologic agents for treating rheumatoid arthritis.

  2001cites this paper
• Pharmacotherapy of Rheumatoid Arthritis: An Overview

  2001cites this paper
• Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia.

  2001cites this paper
• Polyclonal and Monoclonal Antibodies

  2001cites this paper
• From bench to bedside: discovering rules for antibody design, and improving serotherapy with monoclonal antibodies.

  2001cites this paper
• Modern Immunosuppressives

  2001cites this paper
• Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.

  2001cites this paper
• Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys.

  2001cites this paper
• Omega-3 Polyunsaturated Fatty Acids and Rheumatoid Arthritis

  2000cites this paper
• New treatment possibilities in rheumatoid arthritis: REVIEW

  2000cites this paper
• Current treatment practice in immunosuppression

  2000cites this paper
• HIV and the immune system during highly active antiretroviral therapy

  2000influential citation
• The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration.

  2000cites this paper
• Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled study.

  2000cites this paper
• Pharmacokinetic, pharmacodynamic and clinical effects of a humanized IgG1 anti-CD4 monoclonal antibody in the peripheral blood and synovial fluid of rheumatoid arthritis patients.

  2000cites this paper
• New treatment possibilities in rheumatoid arthritis.

  2000cites this paper
• Differential effects of administration of a human anti-CD4 monoclonal antibody, HM6G, in nonhuman primates.

  1999cites this paper
• Treatment with monoclonal anti-tumor necrosis factor alpha antibody results in an accumulation of Th1 CD4+ T cells in the peripheral blood of patients with rheumatoid arthritis.

  1999cites this paper
• Anti-T cell strategies in asthma

  1999cites this paper
• Suppression of systemic lupus erythematosus disease in mice by oral administration of kidney extract.

  1999cites this paper
• Anti-proliferative effects induced by anti-CD4 human/murine chimeric antibody and murine anti-CD4 monoclonal antibody.

  1999cites this paper
• Cytokines and their role in the pathophysiology of osteoarthritis.

  1999cites this paper
• New therapeutic targets for rheumatoid arthritis

  1999cites this paper
• T cell dynamics in HIV-1 infection.

  1999cites this paper
• Treatment of Systemic Lupus Erythematosus by Selective Inhibition of T-Cell Function

  1999cites this paper
• The role of T-cells in rheumatoid arthritis and the use of immunomodulating drugs.

  1999cites this paper
• Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.

  1999cites this paper
• Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws.

  1999cites this paper
• Management of therapy-resistant rheumatoid arthritis.

  1999cites this paper
• Anti-CD4-Therapie in der Behandlung der rheumatoiden Arthritis – sind die Würfel schon gefallen?

  1998cites this paper
• Early recovery of CD 4 + T lymphocytes in children on highly active antiretroviral therapy

  1998cites this paper
• [Anti-CD4 therapy in treatment of rheumatoid arthritis--have the die been cast?].

  1998cites this paper
• T cell directed therapies and biologics

  1998cites this paper
• Clinical and immunologic effects of a PRIMATIZED anti-CD4 monoclonal antibody in active rheumatoid arthritis: results of a phase I, single dose, dose escalating trial.

  1998cites this paper
• Early recovery of CD4+ T lymphocytes in children on highly active antiretroviral therapy

  1998cites this paper
• Opportunities for future biological therapy in SLE.

  1998cites this paper
• T cells as secondary players in rheumatoid arthritis

  1998cites this paper
• 9 Opportunities for future biological therapy in SLE

  1998cites this paper
• Nondepleting humanized anti-CD4 monoclonal antibody in patients with refractory rheumatoid arthritis.

  1998cites this paper
• STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13.

  1998cites this paper
• IL-13 on Stimulation with Th 2 Cytokines IL-4 and Lymphocytes and Is Produced by Monocytes Specifically on Chronically Activated Th 2 STCP-1 ( MDC ) CC Chemokine Acts

  1998cites this paper
• Treatment of recalcitrant plaque psoriasis with a humanized non-depleting antibody to CD4.

  1998cites this paper
• Clinical trials on biologics in rheumatoid arthritis.

  1998cites this paper
• Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma.

  1998cites this paper
• Monoclonal antibodies to CD4.

  1998cites this paper
• [Pathogenesis of rheumatoid arthritis].

  1997cites this paper
• Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor alpha receptor gene.

  1997cites this paper
• Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.

  1997cites this paper
• Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy.

  1997cites this paper
• Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease.

  1997cites this paper
• T-cell regeneration: all repertoires are not created equal.

  1997cites this paper
• Effect of Boar Seminal Immunosuppressive Component on Humoral Immune Response in Mice

  1997cites this paper
• Pathways of T‐cell regeneration in mice and humans: implications for bone marrow transplantation and immmunotherapy

  1997cites this paper
• Thymic aging and T‐cell regeneration

  1997cites this paper
• Inhibition of bacterial and boar epididymal sperm immunogenicity by boar seminal immunosuppressive component in mice.

  1997cites this paper
• Persistent long-term changes in lymphocyte subsets induced by polyclonal antibodies.

  1997cites this paper